Using conditioned place preference to identify relapse prevention medications
- 1 November 2013
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 37 (9) , 2081-2086
Abstract
No abstract availableKeywords
Funding Information
- A.A. Herrold (DA023306)
- S.M. Graves (DA024923)
- A.L. Persons (formerly Mickiewicz (DA019783)
- R.M. Voigt (DA021475)
- F. Daniel and Ada L. Rice Foundation (TCN) (DA015760)
- Dr. de Wit's laboratory (DA02812 (HdW))
- Alcoholic Beverage Medical Research Foundation (EC)
This publication has 82 references indexed in Scilit:
- Mirtazapine to Reduce Methamphetamine UseArchives of General Psychiatry, 2011
- Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in ratsBehavioural Brain Research, 2011
- Mirtazapine Alters Cue-Associated Methamphetamine Seeking in RatsBiological Psychiatry, 2011
- Administration of GABAB receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preferenceBehavioural Brain Research, 2011
- Principles of laboratory assessment of drug abuse liability and implications for clinical developmentDrug and Alcohol Dependence, 2009
- Amphetamine-Induced Place Preference in HumansBiological Psychiatry, 2009
- Positive Allosteric Modulation of mGluR5 Receptors Facilitates Extinction of a Cocaine Contextual MemoryBiological Psychiatry, 2009
- Individual differences in the attribution of incentive salience to reward-related cues: Implications for addictionNeuropharmacology, 2009
- On habits and addiction: an associative analysis of compulsive drug seekingDrug Discovery Today: Disease Models, 2008
- Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessationInternational Journal of Neuropsychopharmacology, 2008